Paolo Tarantino: Forever grateful to mentor and friend Joey Curigliano

Paolo Tarantino posted the following on X:

“Here’s to a mentor, a friend, a fierce cancer opponent, and to the upcoming President of the great society that made ESMO24 and many scientific advancements possible. Forever grateful for having had the luck to encounter Joey Curigliano on my path.”

Source: Paolo Tarantino/X

Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.

His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer.

Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology. He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.